21 Jun 2023 Research
Prestigious jointly-funded fellowship could be catalyst for myeloma prevention
The three-year project is set to investigate which patients with smouldering myeloma – a pre-cancerous condition – will progress to myeloma, a type of blood cancer affecting almost 6000 people each year.
Dr Ainley’s research will specifically explore the diverse and changing nature of B cells of the immune system – could they hold the key to preventing progression?
Greater knowledge about how B cells are involved could be a game-changer, ultimately leading to earlier diagnosis or even prevention of this currently incurable type of blood cancer.
Find out more about Dr Ainley’s research.
19 June 2023
Leukaemia UK research paves the way for personalised lymphoma treatment
Despite promising trials, standard treatment for diffuse large B-cell lymphoma (DLBCL) hasn’t changed in a decade. New treatment strategies for this type of blood cancer are urgently needed. Could the…
22 May 2023
Can the unique differences between stem cells tell us how well CML treatment will work?
What if we could predict how chronic myeloid leukaemia (CML) patients will respond to treatment? Could the unique signatures of CML stem cells hold the key to personalising treatment for…
21 April 2023
Trailblazing research project announced to exploit novel weaknesses in one of the least survivable cancers
A pioneering new study hopes to accelerate progress towards a new treatment for acute myeloid leukaemia (AML) in research announced today on World AML Day by Leukaemia UK. University of…
10 January 2023
Clinical trial begins for pioneering new cancer treatment
Dr Konstantinos Tzelepis was awarded a Leukaemia UK research fellowship in 2020 and has developed a new class of cancer drug with the potential to treat leukaemia.